Inhibiting CXCR6 promotes senescence of activated hepatic stellate cells with limited proinflammatory SASP to attenuate hepatic fibrosis
This study investigates the previously unexplored role of CXC chemokine receptor 6 (CXCR6) in hepatic fibrosis, where excessive extracellular matrix deposition by activated hepatic stellate cells (aHSCs) drives disease progression. Through analysis of gene expression omnibus datasets and human fibro...
Saved in:
| Main Authors: | Sheng Liqin, Wu Yiming, Shen Fei, Xu Chenzhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2025-08-01
|
| Series: | Open Life Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/biol-2025-1151 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Notoginsenoside R2 attenuates hepatic fibrosis via STAT3-dependent hepatic stellate cells senescence induction and inflammatory microenvironment suppression
by: Kaili Deng, et al.
Published: (2025-09-01) -
Fangchinoline attenuates hepatic fibrosis by regulating taurine metabolism and oxidative stress
by: Hui Yin, et al.
Published: (2025-08-01) -
Therapeutic Potential of PDA@CeO2 in Suppressing Hepatic Stellate Cell Activation and Preventing Liver Fibrosis
by: Li HM, et al.
Published: (2025-07-01) -
Hepatic stellate cell-specific miR-214 expression alleviates liver fibrosis without boosting steatosis and inflammation
by: Fangqing Zhao, et al.
Published: (2025-07-01) -
Chondroitin Sulfate-Based Imatinib Nanoparticles Targeting Activated Hepatic Stellate Cells Against Hepatic Fibrosis
by: Xunzhi Liu, et al.
Published: (2025-03-01)